Task: Answer the multiple choice question.
Question: Which compound exhibits a 16.264% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: O=c1[nH]c2ccc(S(=O)(=O)NCCO)cc2[nH]1
b: O=C(CSc1nnnn1CCCO)Nc1ccc2c(c1)OCO2
c: COc1ccccc1NC(=S)NNC(=O)c1cc(C)nn1C
Answer: b. O=C(CSc1nnnn1CCCO)Nc1ccc2c(c1)OCO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CSc1nnnn1CCCO)Nc1ccc2c(c1)OCO2
O=C(CSc1nnnn1CCCO)Nc1ccc2c(c1)OCO2
N-(1,3-benzodioxol-5-yl)-2-[1-(3-hydroxypropyl)tetrazol-5-yl]sulfanylacetamide